Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
New Insights into Solid Tumor Cancers
Whole Genome Copy Number Analyses Reveal Novel Druggable Targets
- The first-line treatment for cancer treatment is usually surgery, with many patients also receiving radiation and chemotherapy. However, chemotherapy has significant side effects, and benefits may be short lived with many patients becoming therapy-resistant. As a result, pharmaceutical researchers and oncologists are increasingly using a personalized medicine approach to ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.